Succeeding under Pressure

Program Overview

Join us for this Interactive Showcase™ in narcolepsy!

Bring your MOBILE DEVICE* and HEADPHONES* and immerse yourself in a dynamic, three-part educational experience designed to engage, inform, and inspire clinical practice change.

Begin with an EXPERT-GUIDED POSTER TOUR that highlights emerging insights into the epidemiologic and pathophysiologic connections between narcolepsy and cardiovascular and cardiometabolic risk.

Next, participate in a LIVE FACULTY-LED SESSION where experts will translate these findings into clinical context, discussing their practical implications alongside the latest clinical trial data to inform evidence-based evaluation and management of both adult and pediatric patients with narcolepsy.

Conclude with an INTERACTIVE CASE-BASED ACTIVITY, where you will apply newly acquired knowledge to real-time clinical decision-making in a highly engaging, learner-centered environment.

Don’t miss this opportunity to deepen your understanding and enhance your approach to managing narcolepsy across patient populations!

*A limited number of mobile phones and headphones will be available for loan if needed.

Target Audience

The educational design of this activity addresses the needs of sleep medicine clinicians, pulmonologists, neurologists, cardiologists, psychiatrists (MDs, NPs, PAs) who play a pivotal role in the management of adult and pediatric patients with narcolepsy.

Educational Objectives

After completing this activity, the participant should be better able to:

1. Describe the pathophysiology and unmet burdens of narcolepsy with a focus on cardiovascular, cardiometabolic, and renal risks
2. Discuss recently published evidence and practical prescribing considerations for the pharmacologic treatment of adult and pediatric patients with narcolepsy
3. Tailor multimodal therapeutic plans for narcolepsy based on long-term treatment goals, including sleep quality and stability, sodium-associated negative clinical outcomes, comorbidities, and shared decision making with patients

Program Agenda

6:15 pm-6:30 pm              Onsite Registration
6:30 pm-6:35 pm              Preactivity Questionnaire
6:35 pm-6:50 pm              Multimedia Poster Gallery: Cardiovascular, Cardiometabolic, and Renal Burdens in Narcolepsy
6:50 pm-7:00 pm              Buffet Dinner
7:00 pm-7:50 pm              Meet the Experts Discussion on Achieving Multidimensional Outcomes in Narcolepsy
7:50 pm-8:00 pm              Audience Q&A
8:00 pm-8:10 pm              Case-Based Decision Tree
8:10 pm-8:15 pm              Postactivity Questionnaire

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Reciprocity Statement

The ANCC’s Commission on Accreditation recognizes educational activities that are approved for AMA PRA Category 1 Credits™ by providers who are accredited by the ACCME to award credit to learners. This reciprocity agreement allows nurses and nurse practitioners to use AMA PRA Category 1 Credits™ as approved ANCC contact hours for license renewal.

Integritas Contact Information

For more information about the approval of this program, please contact Integritas at info@exchangecme.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must attend the live symposium and complete the posttest and program evaluation.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Conflicts of Interest

Integritas adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Integritas are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas.  All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

The planners and managers have no relevant financial relationships with ineligible companies.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas does not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.